eMedicine Specialties > Neurology > Neurological Emergencies

Cerebellar Hemorrhage

Author: J Stephen Huff, MD, Associate Professor, Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia Health Sciences Center
Contributor Information and Disclosures

Updated: Dec 11, 2008

Introduction

Background

Advances in neuroimaging have led to revision of treatment concepts for cerebellar hemorrhage (CH). In the pre–computed tomography (CT) era, patients with large hematomas (which were detected by angiography or at postmortem examination) were overrepresented in clinical series. Surgical therapy was stressed. With the availability of cranial CT, patients with milder symptoms and smaller hematomas are increasingly detected. Nonsurgical management has been found to be effective in some of these patients. Management recommendations are still being optimized to improve outcomes.

Pathophysiology

CHs result from the same causes as other intracerebral hemorrhages. Long-standing hypertension with degenerative changes in the vessel walls and subsequent rupture is believed to be the most common cause of a typical cerebellar hemorrhage.

Hemorrhage from tumors, blood dyscrasias, amyloid angiopathy, arteriovenous malformations, trauma, and sympathomimetic abuse are less common causes of CH.

Cerebellar hemorrhages are rarely reported in patients following supratentorial surgery, spinal surgery, and in patients with spontaneous intracranial hypotension.1,2 The mechanism is thought to be removal of large amounts of cerebrospinal fluid (CSF) or continuing CSF leak from dural breach. The hemorrhage is remote from the surgical site or anatomic defect and may result from transient occlusion or rupture of superior cerebellar bridging veins.

Location of the hemorrhage (midline vs hemispheric) is important in determining symptoms and clinical course. It may be more important than absolute hematoma size for prognosis. Generally speaking, the more lateral the hemorrhage and the smaller the hematoma, the more likely the brainstem structures are spared and the better the prognosis.

Development of obstructive hydrocephalus from ventricular compression may lead to increased intracranial pressure and decreased cerebral perfusion pressure.

Brainstem damage by compression from an expanding mass in the posterior fossa is a common and feared complication.

Frequency

United States

An estimated 10% of intracerebral hemorrhages are believed to be cerebellar in location. An estimated 1-2% of strokes are CHs.

International

Up to 30-45% of strokes are intracerebral hemorrhages in some Chinese and Japanese series. Approximately 10% of these may be cerebellar in origin.

Mortality/Morbidity

Mortality rates are unknown but are related to the size of the hematoma, location, and compression of adjacent brainstem structures.

Race

In US population studies, CH is more common in blacks than in other races.

Sex

No gender predilection exists for CH.

Age

CH may occur at any age, depending on the etiology. Generally, incidence increases with age; most hypertensive hemorrhages occur in patients older than 50 years. Rupture of a vascular malformation may be the most common cause in children.

Clinical

History

  • Onset of symptoms is generally abrupt.
  • Presentation varies greatly, depending on the size and location of the hemorrhage. Some patients are alert with headache and perhaps vomiting; others may be unresponsive with impaired or absent brainstem reflexes.
  • The following symptoms are roughly in descending order of incidence:
    • Headache of abrupt onset
    • Nausea and vomiting
    • Inability to walk (reflecting truncal ataxia)
    • Dizziness, vertigo
    • Dysarthria
    • Nuchal pain
    • Loss or alteration of consciousness

Physical

  • Physical examination findings also are variable. Some patients are alert and cooperative, while others are in a coma.
  • Signs generally are of abrupt onset and may change suddenly with progressive expansion of hematoma.
  • Signs tend to cluster with level of consciousness.
    • Diminished level of consciousness (uncooperative to comatose)
      • Irregular respirations
      • Extensor plantar responses
      • Impaired oculocephalic responses and a variety of other abnormal eye movements
      • Decreased or absent corneal responses
      • Impaired or absent pupillary responses
    • Lateralizing cerebellar signs may be present in a patient who is alert enough to cooperate with examination.
      • Limb ataxia
      • Dysarthria
      • Possible presence of extensor plantar responses (unilateral or bilateral)
      • Nuchal rigidity
      • Nystagmus
      • Gaze palsy (ipsilateral to hematoma)
      • Facial weakness
    • Noncardiac or neurogenic cardiopulmonary complications may include findings of pulmonary edema, hypertension, bradycardia, and arrhythymia.3

Causes

Causes are similar to those of other types of intracranial hemorrhage. Approximately two thirds of CHs are believed to be hypertensive hemorrhages.

  • Hypertension - Suspected rupture of small penetrating vessels
  • Amyloid angiopathy
  • Anticoagulant use
  • Blood dyscrasias
  • Arteriovenous malformation rupture
  • Sympathomimetic drug use
  • Hemorrhage into tumor
  • Dural leak or large CSF removal associated with supratentorial surgery, spinal surgery, or spontaneous intracranial hypotension.

More on Cerebellar Hemorrhage

Overview: Cerebellar Hemorrhage
Differential Diagnoses & Workup: Cerebellar Hemorrhage
Treatment & Medication: Cerebellar Hemorrhage
Follow-up: Cerebellar Hemorrhage
Multimedia: Cerebellar Hemorrhage
References

References

  1. Brockmann MA, Groden C. Remote cerebellar hemorrhage: a review. Cerebellum. 2006;5(1):64-8. [Medline].

  2. Konya D, Ozgen S, Pamir MN. Cerebellar hemorrhage after spinal surgery: case report and review of the literature. Eur Spine J. Jan 2006;15(1):95-9. [Medline].

  3. Young YR, Lee CC, Sheu BF, Chang SS. Neurogenic cardiopulmonary complications associated with spontaneous cerebellar hemorrhage. Neurocrit Care. 2007;7(3):238-40. [Medline].

  4. St Louis EK, Wijdicks EF, Li H. Predicting neurologic deterioration in patients with cerebellar hematomas. Neurology. Nov 1998;51(5):1364-9. [Medline].

  5. Mohadjer M, Eggert R, May J, Mayfrank L. CT-guided stereotactic fibrinolysis of spontaneous and hypertensive cerebellar hemorrhage: long-term results. J Neurosurg. Aug 1990;73(2):217-22. [Medline].

  6. Chalela JA, Monroe T, Kelley M, Auler M, Bryant T, Vandergrift A, et al. Cerebellar hemorrhage caused by remote neurological surgery. Neurocrit Care. 2006;5(1):30-4. [Medline].

  7. Deininger MH, Adam A, Van Velthoven V. Free-hand bedside catheter evacuation of cerebellar hemorrhage. Minim Invasive Neurosurg. Feb 2008;51(1):57-60. [Medline].

  8. Arboix A, Bell Y, Garcia-Eroles L, et al. Clinical study of 35 patients with dysarthria-clumsy hand syndrome. J Neurol Neurosurg Psychiatry. Feb 2004;75(2):231-4. [Medline].

  9. Ausman JI. How I remove a spontaneous cerebellar hematoma in a deteriorating patient. Surg Neurol. Mar 2001;55(3):162. [Medline].

  10. Broderick J, Brott T, Tomsick T, et al. Management of intracerebral hemorrhage in a large metropolitan population. Neurosurgery. May 1994;34(5):882-7; discussion 887. [Medline].

  11. Chin D, Carney P. Acute cerebellar hemorrhage with brainstem compression in contrast with benign cerebellar hemorrhage. Surg Neurol. May 1983;19(5):406-9. [Medline].

  12. Dolderer S, Kallenberg K, Aschoff A, et al. Long-term outcome after spontaneous cerebellar haemorrhage. Eur Neurol. 2004;52(2):112-9. [Medline].

  13. Fisher CM, Picard EH, Polak A, et al. Acute hypertensive cerebellar hemorrhage: diagnosis and surgical treatment. J Nerv Ment Dis. Jan 1965;140:38-57. [Medline].

  14. Huff JS. Dr. C. Miller Fisher's description of acute cerebellar hemorrhage. J Emerg Med. Jul-Aug 1994;12(4):521-4. [Medline].

  15. Kubo T, Sakata Y, Sakai S, et al. Clinical observations in the acute phase of cerebellar hemorrhage and infarction. Acta Otolaryngol Suppl. 1988;447:81-7. [Medline].

  16. Martin AJ, Thomas NW. Evolving traumatic cerebellar hematoma. Neurology. Nov 13 2001;57(9):1565. [Medline].

  17. Pollak L, Rabey JM, Gur R, Schiffer J. Indication to surgical management of cerebellar hemorrhage. Clin Neurol Neurosurg. Jun 1998;100(2):99-103. [Medline].

  18. Rosen RS, Armbrustmacher V, Sampson BA. Spontaneous cerebellar hemorrhage in children. J Forensic Sci. Jan 2003;48(1):177-9. [Medline].

  19. Salvati M, Cervoni L, Raco A, Delfini R. Spontaneous cerebellar hemorrhage: clinical remarks on 50 cases. Surg Neurol. Mar 2001;55(3):156-61; discussion 161. [Medline].

  20. Schievink WI, Maya MM. Quadriplegia and cerebellar hemorrhage in spontaneous intracranial hypotension. Neurology. Jun 13 2006;66(11):1777-8. [Medline].

  21. Taneda M, Hayakawa T, Mogami H. Primary cerebellar hemorrhage. Quadrigeminal cistern obliteration on CT scans as a predictor of outcome. J Neurosurg. Oct 1987;67(4):545-52. [Medline].

  22. Wijdicks EFM. Cerebellum and brain stem hemorrhages. In: The Clinical Practice of Critical Care Neurology. Lippincott-Raven; 1997:173-182.

  23. Yamamoto T, Nakao Y, Mori K. Endoscopic hematoma evacuation for hypertensive cerebellar hemorrhage. Minim Invasive Neurosurg. Jun 2006;49(3):173-8. [Medline].

Further Reading

Keywords

CH, cerebellar bleeding, intracerebellar hemorrhage, stroke of the cerebellum, stroke, computed tomography, head CT, cranial CT

Contributor Information and Disclosures

Author

J Stephen Huff, MD, Associate Professor, Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia Health Sciences Center
J Stephen Huff, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Draga Jichici, BSc, MD, FRCP, Associate Clinical Professor, Department of Medicine, Division of Neurology and Critical Care Medicine, McMaster University, Canada
Disclosure: Biogen Honoraria Review panel membership; Sanofi Honoraria Speaking and teaching; Merk and Frost Honoraria Speaking and teaching; Teva Neurosciences Honoraria Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Howard S Kirshner, MD, Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center
Howard S Kirshner, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neurorehabilitation, National Stroke Association, Phi Beta Kappa, and Tennessee Medical Association
Disclosure: Boehringer Ingelheim Honoraria Speaking and teaching; BMS/Sanofi Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Novartis Consulting fee Review panel membership

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Helmi L Lutsep, MD, Professor, Department of Neurology, Oregon Health and Science University; Associate Director, Oregon Stroke Center
Helmi L Lutsep, MD is a member of the following medical societies: American Academy of Neurology and American Stroke Association
Disclosure: Co-Axia Consulting fee Review panel membership; Talecris Consulting fee Review panel membership; AGA Medical Consulting fee Review panel membership; Boehringer Ingelheim Honoraria Speaking and teaching; Boston Scientific Honoraria Speaking and teaching; Concentric Medical None Review panel membership; Northstar Neuroscience  Review panel membership; ev3 Consulting fee Review panel membership

RELATED EMEDICINE ARTICLES
Patient Education
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.